UPDATE 1-AstraZeneca's ovarian cancer drug gets U.S. approval
December 19, 2014 at 13:33 PM EST
Dec 19 (Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.